BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8793483)

  • 1. Mutation spectrum of p53 gene in highly malignant human osteosarcomas.
    Radig K; Schneider-Stock R; Oda Y; Neumann W; Mittler U; Roessner A
    Gen Diagn Pathol; 1996 Jun; 142(1):25-32. PubMed ID: 8793483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas.
    Toguchida J; Yamaguchi T; Ritchie B; Beauchamp RL; Dayton SH; Herrera GE; Yamamuro T; Kotoura Y; Sasaki MS; Little JB
    Cancer Res; 1992 Nov; 52(22):6194-9. PubMed ID: 1423262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
    Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
    Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors.
    Soong R; Iacopetta BJ
    Mod Pathol; 1997 Mar; 10(3):252-8. PubMed ID: 9071734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 gene mutations in osteosarcomas of low-grade malignancy.
    Radig K; Schneider-Stock R; Haeckel C; Neumann W; Roessner A
    Hum Pathol; 1998 Nov; 29(11):1310-6. PubMed ID: 9824113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of the p53 gene in postradiation sarcoma.
    Nakanishi H; Tomita Y; Myoui A; Yoshikawa H; Sakai K; Kato Y; Ochi T; Aozasa K
    Lab Invest; 1998 Jun; 78(6):727-33. PubMed ID: 9645763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COPS3 amplification and clinical outcome in osteosarcoma.
    Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
    Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary malignant lymphoma of the brain: demonstration of the p53 gene mutations by PCR-SSCP analysis and immunohistochemistry.
    Koga H; Zhang S; Ichikawa T; Washiyama K; Kuroiwa T; Tanaka R; Kumanishi T
    Noshuyo Byori; 1994; 11(2):151-5. PubMed ID: 7894617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of p53 mutations with metastatic prostate cancer.
    Eastham JA; Stapleton AM; Gousse AE; Timme TL; Yang G; Slawin KM; Wheeler TM; Scardino PT; Thompson TC
    Clin Cancer Res; 1995 Oct; 1(10):1111-8. PubMed ID: 9815901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 mutation is infrequent in clear cell carcinoma of the ovary.
    Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
    Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation spectrum of the retinoblastoma gene in osteosarcomas.
    Wadayama B; Toguchida J; Shimizu T; Ishizaki K; Sasaki MS; Kotoura Y; Yamamuro T
    Cancer Res; 1994 Jun; 54(11):3042-8. PubMed ID: 8187094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of SV40 in human osteosarcoma DNA.
    Mendoza SM; Konishi T; Miller CW
    Oncogene; 1998 Nov; 17(19):2457-62. PubMed ID: 9824156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The significance of p53 gene mutations and expressions in human colorectal tumors].
    Qian H; Yu B; Zhou X
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):332-5. PubMed ID: 8697968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular analysis of tumor suppressor genes p16INK4 and TP53 of osteosarcomas in Spanish children].
    Patiño García A; Sierrasesúmaga Ariznabarreta L
    An Esp Pediatr; 1997 Nov; 47(5):478-82. PubMed ID: 9586287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
    Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
    Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
    Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53 gene abnormalities in osteosarcoma.
    Guo W; Wang X; Feng C
    Chin Med J (Engl); 1996 Oct; 109(10):752-5. PubMed ID: 9275350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.